View in EDS

First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20+ Non-Hodgkin Lymphomas.

Saved in:
Bibliographic Details
Title: First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20+ Non-Hodgkin Lymphomas.
Authors: Gopal AK; University of Washington, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle, Washington. AGopal@u.washington.edu., Levy R; Stanford Cancer Center, Stanford, California., Houot R; 1 CHU Rennes, Service Hématologie Clinique Rennes, France.; University of Rennes, EFS, Microenvironment, Cell Differentiation, Immunology and Cancer Rennes, France.; INSERM 0203, Unité d'Investigation Clinique, Rennes, France., Patel SP; University of California at San Diego Moores Cancer Center, San Diego, California., Popplewell L; City of Hope National Medical Center, Duarte, California., Jacobson C; Dana-Farber Cancer Institute, Boston, Massachusetts., Mu XJ; Pfizer Oncology, San Diego, California., Deng S; Pfizer Oncology, San Diego, California., Ching KA; Pfizer Oncology, San Diego, California., Chen Y; Pfizer Oncology, San Diego, California., Davis CB; Pfizer Oncology, San Diego, California., Huang B; Pfizer Oncology, Groton, Connecticut., Fly KD; Pfizer Oncology, Groton, Connecticut., Thall A; Pfizer Oncology, San Diego, California., Woolfson A; Pfizer Oncology, New York, New York., Bartlett NL; Washington University School of Medicine, Siteman Cancer Center, St Louis, Missouri.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Jun 01; Vol. 26 (11), pp. 2524-2534. Date of Electronic Publication: 2020 Mar 06.
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32144134
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20<superscript>+</superscript> Non-Hodgkin Lymphomas.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gopal+AK%22">Gopal AK</searchLink>; University of Washington, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle, Washington. AGopal@u.washington.edu.<br /><searchLink fieldCode="AU" term="%22Levy+R%22">Levy R</searchLink>; Stanford Cancer Center, Stanford, California.<br /><searchLink fieldCode="AU" term="%22Houot+R%22">Houot R</searchLink>; 1 CHU Rennes, Service Hématologie Clinique Rennes, France.; University of Rennes, EFS, Microenvironment, Cell Differentiation, Immunology and Cancer Rennes, France.; INSERM 0203, Unité d'Investigation Clinique, Rennes, France.<br /><searchLink fieldCode="AU" term="%22Patel+SP%22">Patel SP</searchLink>; University of California at San Diego Moores Cancer Center, San Diego, California.<br /><searchLink fieldCode="AU" term="%22Popplewell+L%22">Popplewell L</searchLink>; City of Hope National Medical Center, Duarte, California.<br /><searchLink fieldCode="AU" term="%22Jacobson+C%22">Jacobson C</searchLink>; Dana-Farber Cancer Institute, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Mu+XJ%22">Mu XJ</searchLink>; Pfizer Oncology, San Diego, California.<br /><searchLink fieldCode="AU" term="%22Deng+S%22">Deng S</searchLink>; Pfizer Oncology, San Diego, California.<br /><searchLink fieldCode="AU" term="%22Ching+KA%22">Ching KA</searchLink>; Pfizer Oncology, San Diego, California.<br /><searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink>; Pfizer Oncology, San Diego, California.<br /><searchLink fieldCode="AU" term="%22Davis+CB%22">Davis CB</searchLink>; Pfizer Oncology, San Diego, California.<br /><searchLink fieldCode="AU" term="%22Huang+B%22">Huang B</searchLink>; Pfizer Oncology, Groton, Connecticut.<br /><searchLink fieldCode="AU" term="%22Fly+KD%22">Fly KD</searchLink>; Pfizer Oncology, Groton, Connecticut.<br /><searchLink fieldCode="AU" term="%22Thall+A%22">Thall A</searchLink>; Pfizer Oncology, San Diego, California.<br /><searchLink fieldCode="AU" term="%22Woolfson+A%22">Woolfson A</searchLink>; Pfizer Oncology, New York, New York.<br /><searchLink fieldCode="AU" term="%22Bartlett+NL%22">Bartlett NL</searchLink>; Washington University School of Medicine, Siteman Cancer Center, St Louis, Missouri.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2020 Jun 01; Vol. 26 (11), pp. 2524-2534. <i>Date of Electronic Publication: </i>2020 Mar 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32144134
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1078-0432.CCR-19-2973
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2524
    Titles:
      – TitleFull: First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20+ Non-Hodgkin Lymphomas.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gopal AK
      – PersonEntity:
          Name:
            NameFull: Levy R
      – PersonEntity:
          Name:
            NameFull: Houot R
      – PersonEntity:
          Name:
            NameFull: Patel SP
      – PersonEntity:
          Name:
            NameFull: Popplewell L
      – PersonEntity:
          Name:
            NameFull: Jacobson C
      – PersonEntity:
          Name:
            NameFull: Mu XJ
      – PersonEntity:
          Name:
            NameFull: Deng S
      – PersonEntity:
          Name:
            NameFull: Ching KA
      – PersonEntity:
          Name:
            NameFull: Chen Y
      – PersonEntity:
          Name:
            NameFull: Davis CB
      – PersonEntity:
          Name:
            NameFull: Huang B
      – PersonEntity:
          Name:
            NameFull: Fly KD
      – PersonEntity:
          Name:
            NameFull: Thall A
      – PersonEntity:
          Name:
            NameFull: Woolfson A
      – PersonEntity:
          Name:
            NameFull: Bartlett NL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2020 Jun 01
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1557-3265
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research
              Type: main
ResultId 1